While the study points out toward the need of systematic testing of p16 overexpression, results obtained in a subset of patients, the results are also in line with a recent study evaluating the 8th TNM classification that integrates p16 status (as independent or surrogate markers for HPV infection) in oropharyngeal cancer [17,45]. The gene discussed is CDKN2A; the disease is oropharynx cancer.